Zhang, H., Saha, J., Byun, J., Schin, M., Lorenz, M., Kennedy, R. T., . . . Brosius, F. C. (2008). Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. American Physiological Society.
シカゴスタイル引用形Zhang, Hongyu, et al. Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy. American Physiological Society, 2008.
MLA引用形式Zhang, Hongyu, et al. Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy. American Physiological Society, 2008.